Quick Answer
Chemours Co reported Cash and Equivalents of $670.00 million for fiscal year 2025.
Chemours Co Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $670.00M | -6.0% |
| 2024 | $713.00M | -40.7% |
| 2023 | $1.20B | +9.2% |
| 2022 | $1.10B | -24.1% |
| 2021 | $1.45B | +31.3% |
| 2020 | $1.10B | +17.2% |
| 2019 | $943.00M | -21.5% |
| 2018 | $1.20B | -22.8% |
| 2017 | $1.56B | +72.5% |
| 2016 | $902.00M | +146.4% |
| 2015 | $366.00M | — |
| 2014 | $0.00 | — |
| 2013 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $613.00M | +2.9% | +22.1% |
| June 30, 2025 | $502.00M | -16.9% | +8.2% |
| March 31, 2025 | $464.00M | -37.8% | -34.9% |
| December 31, 2024 | $713.00M | -40.7% | +19.6% |
| September 30, 2024 | $596.00M | -30.0% | -1.3% |
| June 30, 2024 | $604.00M | -18.2% | -19.0% |
| March 31, 2024 | $746.00M | -8.6% | -38.0% |
| December 31, 2023 | $1.20B | +9.2% | +41.2% |
- Chemours Co showed a decrease of -6.0% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from Chemours Co’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: